Will the FDA reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by December 31, 2026?

**Market Overview** The prediction market "Will the FDA reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by December 31, 2026?" is currently trading at 35.5% on Polymarket, reflecting real-time sentiment and odds from 15 active participants. As of July 15, 2026, this market has generated $992 in total trading volume, making it an emerging prediction market in the general category. **Current Odds & Price Action** The "Yes" outcome is priced at 35.5%, while "No" trades at 64.5%. The market has remained relatively stable over the past 24 hours, suggesting established consensus among traders about the likely outcome. **Liquidity & Trading Conditions** This market offers $1.4K in liquidity, suitable for retail-sized positions. **Market Timeline** This prediction market will remain open for 169 more days (until Dec 31, 2026), providing ample time for price discovery as new information emerges.